Alfonso Ávila Robinson

Alfonso Ávila Robinson serves as Professor in the Department of Entrepreneurship and Technological Innovation at EGADE Business School, Tecnológico de Monterrey. His expertise bridges technological innovation management with emerging life science applications, emphasizing data-driven approaches to interdisciplinary R&D.

Education:

• PhD in Technology Management and Innovation, Tokyo Institute of Technology (Japan)
• Master's Degree in Manufacturing Engineering, RWTH Aachen (Germany)
• Bachelor's Degree in Industrial and Systems Engineering, University of Monterrey

His research centers on technological innovation management, with specialized focus on data science applications, network analysis of knowledge flows, and emerging technology forecasting. He investigates interdisciplinary R&D dynamics in high-tech sectors—particularly stem cell therapies, regenerative medicine, and nanotechnology—examining how scientific discoveries translate into commercial ventures. His work integrates technology intelligence frameworks with life sciences innovation, drawing on extensive field experience in Japan's regenerative medicine ecosystem.

Publication analysis (2013-2019) reveals consistent focus on bibliometric and network-based studies of emerging technologies. Key thematic clusters include stem cell innovation systems, MEMS/NEMS technological emergence, and interdisciplinary knowledge integration—demonstrating methodological rigor in scientometrics while addressing real-world challenges in biotechnology commercialization.

Scientific Awards:

• Research grant from MEXT (Japan)
• Research grant from CONACYT (Mexico)

Dr. Ávila Robinson secured competitive international grants from Japan's MEXT and Mexico's CONACYT to investigate technological emergence patterns and stem cell innovation ecosystems. His grant-funded work supports doctoral training in innovation management, though specific advisees aren't documented in source materials. He actively contributes to academic discourse as ad hoc reviewer for leading technology management journals.

His research methodology integrates fieldwork from collaborations with Fraunhofer Institute, RWTH Aachen, Tokyo Tech, and Kyoto University, maintaining strong industry linkages in regenerative medicine commercialization through EGADE's innovation research groups.